CHAC1 exacerbates arsenite cytotoxicity by lowering intracellular glutathione levels

Daigo Sumi1, Hiroki Taguchi1, Kumiko Takeuchi1

  • 1Faculty of Pharmaceutical Sciences, Tokushima Bunri University.

PubMed

Insights

CHAC1 regulates intracellular glutathione (GSH) levels, influencing sensitivity to arsenite (As(III)) in HaCaT cells. Downregulating CHAC1 reduces As(III)-induced apoptosis, highlighting CHAC1

Area of Science:

  • Cell Biology
  • Toxicology
  • Biochemistry

Background:

  • Arsenite (As(III)) is a toxic metalloid known to induce cytotoxicity and apoptosis in various cell types.
  • Glutathione (GSH) plays a critical role in cellular defense against oxidative stress and toxic insults.
  • CHAC1 (also known as AIG1) is a gene induced by endoplasmic reticulum stress and implicated in apoptosis.

Purpose of the Study:

  • To investigate the role of CHAC1 in arsenite (As(III))-induced cytotoxicity and apoptosis in HaCaT cells.
  • To determine the relationship between CHAC1 expression, intracellular GSH levels, and As(III) sensitivity.

Main Methods:

  • HaCaT cells were transfected with CHAC1 siRNA to reduce CHAC1 expression.
  • Cells were treated with arsenite (As(III)) and/or buthionine sulfoximine (BSO), an inhibitor of GSH biosynthesis.
  • Intracellular GSH levels, cell viability, and apoptosis (caspase-3 cleavage) were assessed.

Main Results:

  • Downregulation of CHAC1 led to decreased sensitivity to As(III)-induced cytotoxicity.
  • Elevated intracellular GSH levels in CHAC1-depleted cells correlated with reduced As(III) sensitivity.
  • As(III) exposure increased CHAC1 expression and induced apoptosis, which was abrogated in CHAC1 siRNA-transfected cells.

Conclusions:

  • CHAC1 is involved in regulating intracellular GSH levels, thereby modulating HaCaT cell sensitivity to arsenite.
  • CHAC1 plays a significant role in As(III)-induced apoptosis in HaCaT cells.
  • Targeting CHAC1 may offer a strategy to mitigate arsenite toxicity.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
918
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
715
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
253
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
680
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K